|
Volumn 330, Issue 8555, 1987, Pages 353-359
|
RANDOMISED COMPARISON OF CISPLATIN WITH CYCLOPHOSPHAMIDE/CISPLATIN AND WITH CYCLOPHOSPHAMIDE/DOXORUBICIN/ CISPLATIN IN ADVANCED OVARIAN CANCER
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVERSE DRUG REACTION;
CANCER CHEMOTHERAPY;
CELL TYPE;
DRUG COMPARISON;
DRUG MIXTURE;
FEMALE GENITAL SYSTEM;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY CANCER;
PRIORITY JOURNAL;
PROGNOSIS;
THERAPY;
TUMOR VOLUME;
ADENOCARCINOMA, MUCINOUS;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PHOSPHORAMIDE MUSTARDS;
PROGNOSIS;
RANDOM ALLOCATION;
REGRESSION ANALYSIS;
REMISSION INDUCTION;
|
EID: 0023239218
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(87)92381-6 Document Type: Article |
Times cited : (202)
|
References (26)
|